DMSO
What side-effects / risks are associated with cesium chloride / DMSO therapy?
What side-effects / risks are associated with cesium chloride /
DMSO therapy?
Side effects of cesium chloride protocol
Inflammation (swelling) and
pain - this treatment can cause
temporary inflammation of tumor with its
inherent pain. In some areas, inflammation could block flow of key fluids (e.g in
the pancreas or liver), or cause an obstruction (GI tract), or pressure on the brain. In
these cases, it may be necessary to take extra anti-inflammatory measures as described
in instructions.
The following side effects are sometimes present:
• Muscle cramps
- usually due to lowered serum potassium levels;
• Tingly feeling in fingertips is a common,
temporary side-effect - can also occur in lips /face or
feet; generally only lasts for a week or two. Note that this can also be a side-effect
of chemotherapy.
• Numbness within the triangle formed
by the mouth to the tip of the nose;
• Flu-like symptoms, diarrhea, nausea
and vomiting;
• DARK, DRIED blood in urine
- can occur as the kidneys dispose of dead tissue, usually seen in the morning,
not afternoon or evening.
Numbness within the triangle describing the mouth and the tip of the nose.
DMSO has a somewhat unpleasant smell
One drawback when using DMSO with this therapy is its smell,
somewhat akin to garlic, which emanates from your skin and breath
- a small matter when in a desperate situation, but a problem if you need to hold
a job dealing with the public! The bad breath and/or body odor is caused by the
DMSO leaving your body after doing its job. You may want to take a shower
and change your clothes more frequently than usual.
Cesium therapy lowers blood potassium levels
When utilizing the cesium protocol, it is of utmost importance
that potassium levels are replenished (preferably from
potassium-rich foods or else by taking a supplement such as potassium chloride)
and also monitored - those undergoing cesium
therapy should watch for signs of potassium deficiency and have their blood potassium
levels tested every two or three weeks.
FDA report on risks of cesium chloride protocol
FDA identified 5 reports submitted to FDA and 18 published
in the medical literature describing patients who experienced adverse events from
cesium. Seventeen of those reports were associated with CsCl, and 6 with other cesium
salts like cesium carbonate. Most patients took cesium to try to treat cancer. The
doses described in these cases ranged from 500 milligrams taken every day to 100
grams taken over eleven days.
Reported adverse events included QT prolongation (a dangerous
abnormality that can impair the heart's ability to maintain a normal rhythm), low
potassium, seizures, potentially lethal arrhythmias, fainting, cardiac arrest (the
heart stopped beating), and death. QT prolongation
due to low potassium levels in the blood was the most frequently reported adverse
event . QT prolongation in the presence of low potassium usually improves
quickly when potassium is administered,
FDA alerts health care professionals of significant safety risks associated with
cesium chloride
The cesium chloride protocol described
at this website has a maximum daily oral or transdermal
dose of 3 grams cesium -
injected doses should only be administered in a clinical setting.
The adverse reports on cesium chloride treatments should be
kept in perspective - considering the number of detrimental
side-effects of pharmaceutical treatments. E.g. Statin drugs have caused thousands
of verified deaths. Also, many utilizing cesium chloride for therapy do so as a
last resort after a failed mainstream medical treament and are already in a weakened,
late-stage condition.